Thoracoscopic Closure of the Left Atrial Appendage: AtriClip® or Stapler?
This study compares outcomes of thoracoscopic left atrial appendage (LAA) closure using the AtriClip® or an automatic stapler.
This study compares outcomes of thoracoscopic left atrial appendage (LAA) closure using the AtriClip® or an automatic stapler.
The CAST-HF clinical trial results on shockwave therapy for the recovery of hibernating myocardium concurrently with revascularization surgery.
Three-Year Results of the ECSL Registry in Extracorporeal Life Support Patients Receiving HM3 Implants from January 2016 to April 2022 Across 14 Centers, Compared to Other Long-Term Devices.
Observational, single-center, retrospective study analyzing the safety, in terms of hospital mortality and stroke, of cannulation over a dissected right axillary artery.
Results from the experience of six centers in Australia and New Zealand in the management of Ebstein anomaly over 34 years.
This study confirms the findings of the PROACT trial on the safety profile of reducing oral anticoagulation in patients with an On-X® prosthetic valve in the aortic position.
A single-center, retrospective study from Boston Children’s Hospital reports 35 years of experience with truncal root dilatation.
This meta-analysis compares reimplantation and remodeling techniques for valve-sparing aortic root replacement (VSARR) in patients with a dilated aortic root. It includes data from comparative studies on reimplantation and remodeling techniques for VSARR published up to December 31, 2022.
This study, conducted as a prospective, single-center (Tongji Hospital in Wuhan, China), single-arm trial by a single surgeon, is the first in humans to assess the transapical beating-heart septal myectomy (TA-BSM) procedure.
This retrospective study utilized data from the United Network for Organ Sharing (UNOS) and the Pediatric Health Information System (PHIS) to evaluate the outcomes of heart transplantation in children with heterotaxy syndrome. These were compared with outcomes in patients with other congenital heart diseases (CHD) and cardiomyopathies, focusing on survival, rejection, and additional complications.